Gokaldas Exports Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 3, 2025, 8:48 pm

Competitors of Gokaldas Exports Ltd

All Competitor Stocks of Gokaldas Exports Ltd

Quarterly Result

Last Updated: August 20, 2025, 10:15 am

Below is a detailed analysis of the quarterly data for Gokaldas Exports Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 956.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,015.00 Cr. (Mar 2025) to 956.00 Cr., marking a decrease of 59.00 Cr..
• For Expenses, as of Jun 2025, the value is 858.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 893.00 Cr. (Mar 2025) to 858.00 Cr., marking a decrease of 35.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 97.00 Cr.. The value appears to be declining and may need further review. It has decreased from 123.00 Cr. (Mar 2025) to 97.00 Cr., marking a decrease of 26.00 Cr..
• For OPM %, as of Jun 2025, the value is 10.00%. The value appears to be declining and may need further review. It has decreased from 12.00% (Mar 2025) to 10.00%, marking a decrease of 2.00%.
• For Other Income, as of Jun 2025, the value is 21.00 Cr.. The value appears strong and on an upward trend. It has increased from 20.00 Cr. (Mar 2025) to 21.00 Cr., marking an increase of 1.00 Cr..
• For Interest, as of Jun 2025, the value is 22.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 21.00 Cr. (Mar 2025) to 22.00 Cr., marking an increase of 1.00 Cr..
• For Depreciation, as of Jun 2025, the value is 39.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 42.00 Cr. (Mar 2025) to 39.00 Cr., marking a decrease of 3.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 57.00 Cr.. The value appears to be declining and may need further review. It has decreased from 79.00 Cr. (Mar 2025) to 57.00 Cr., marking a decrease of 22.00 Cr..
• For Tax %, as of Jun 2025, the value is 27.00%. The value appears to be improving (decreasing) as expected. It has decreased from 33.00% (Mar 2025) to 27.00%, marking a decrease of 6.00%.
• For Net Profit, as of Jun 2025, the value is 41.00 Cr.. The value appears to be declining and may need further review. It has decreased from 53.00 Cr. (Mar 2025) to 41.00 Cr., marking a decrease of 12.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 5.67. The value appears to be declining and may need further review. It has decreased from 7.40 (Mar 2025) to 5.67, marking a decrease of 1.73.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: October 15, 2025, 5:17 am

Growth

Last Updated: September 5, 2025, 5:05 am

Balance Sheet

Last Updated: June 16, 2025, 12:05 pm

Below is a detailed analysis of the balance sheet data for Gokaldas Exports Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 36.00 Cr.. The value appears strong and on an upward trend. It has increased from 32.00 Cr. (Mar 2024) to 36.00 Cr., marking an increase of 4.00 Cr..
• For Reserves, as of Mar 2025, the value is 2,045.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,260.00 Cr. (Mar 2024) to 2,045.00 Cr., marking an increase of 785.00 Cr..
• For Borrowings, as of Mar 2025, the value is 845.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 805.00 Cr. (Mar 2024) to 845.00 Cr., marking an increase of 40.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 611.00 Cr.. The value appears to be improving (decreasing). It has decreased from 645.00 Cr. (Mar 2024) to 611.00 Cr., marking a decrease of 34.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 3,537.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2,741.00 Cr. (Mar 2024) to 3,537.00 Cr., marking an increase of 796.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 1,399.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,136.00 Cr. (Mar 2024) to 1,399.00 Cr., marking an increase of 263.00 Cr..
• For CWIP, as of Mar 2025, the value is 17.00 Cr.. The value appears to be declining and may need further review. It has decreased from 128.00 Cr. (Mar 2024) to 17.00 Cr., marking a decrease of 111.00 Cr..
• For Investments, as of Mar 2025, the value is 497.00 Cr.. The value appears strong and on an upward trend. It has increased from 159.00 Cr. (Mar 2024) to 497.00 Cr., marking an increase of 338.00 Cr..
• For Other Assets, as of Mar 2025, the value is 1,624.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,318.00 Cr. (Mar 2024) to 1,624.00 Cr., marking an increase of 306.00 Cr..
• For Total Assets, as of Mar 2025, the value is 3,537.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,741.00 Cr. (Mar 2024) to 3,537.00 Cr., marking an increase of 796.00 Cr..

Notably, the Reserves (2,045.00 Cr.) exceed the Borrowings (845.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Gokaldas Exports Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 5.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 5.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 22.36. This value is within the healthy range. It has increased from 21.55 (Mar 24) to 22.36, marking an increase of 0.81.
• For Diluted EPS (Rs.), as of Mar 25, the value is 21.45. This value is within the healthy range. It has increased from 20.51 (Mar 24) to 21.45, marking an increase of 0.94.
• For Cash EPS (Rs.), as of Mar 25, the value is 40.15. This value is within the healthy range. It has increased from 34.67 (Mar 24) to 40.15, marking an increase of 5.48.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 291.14. It has increased from 203.74 (Mar 24) to 291.14, marking an increase of 87.40.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 291.14. It has increased from 203.74 (Mar 24) to 291.14, marking an increase of 87.40.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 540.71. It has increased from 375.32 (Mar 24) to 540.71, marking an increase of 165.39.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 59.32. This value is within the healthy range. It has increased from 44.82 (Mar 24) to 59.32, marking an increase of 14.50.
• For PBIT / Share (Rs.), as of Mar 25, the value is 41.35. This value is within the healthy range. It has increased from 30.82 (Mar 24) to 41.35, marking an increase of 10.53.
• For PBT / Share (Rs.), as of Mar 25, the value is 30.51. This value is within the healthy range. It has increased from 25.08 (Mar 24) to 30.51, marking an increase of 5.43.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 22.18. This value is within the healthy range. It has increased from 20.66 (Mar 24) to 22.18, marking an increase of 1.52.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 22.18. This value is within the healthy range. It has increased from 20.66 (Mar 24) to 22.18, marking an increase of 1.52.
• For PBDIT Margin (%), as of Mar 25, the value is 10.97. This value is within the healthy range. It has decreased from 11.94 (Mar 24) to 10.97, marking a decrease of 0.97.
• For PBIT Margin (%), as of Mar 25, the value is 7.64. This value is below the healthy minimum of 10. It has decreased from 8.21 (Mar 24) to 7.64, marking a decrease of 0.57.
• For PBT Margin (%), as of Mar 25, the value is 5.64. This value is below the healthy minimum of 10. It has decreased from 6.68 (Mar 24) to 5.64, marking a decrease of 1.04.
• For Net Profit Margin (%), as of Mar 25, the value is 4.10. This value is below the healthy minimum of 5. It has decreased from 5.50 (Mar 24) to 4.10, marking a decrease of 1.40.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 4.10. This value is below the healthy minimum of 8. It has decreased from 5.50 (Mar 24) to 4.10, marking a decrease of 1.40.
• For Return on Networth / Equity (%), as of Mar 25, the value is 7.61. This value is below the healthy minimum of 15. It has decreased from 10.14 (Mar 24) to 7.61, marking a decrease of 2.53.
• For Return on Capital Employeed (%), as of Mar 25, the value is 11.53. This value is within the healthy range. It has increased from 11.30 (Mar 24) to 11.53, marking an increase of 0.23.
• For Return On Assets (%), as of Mar 25, the value is 4.48. This value is below the healthy minimum of 5. It has decreased from 4.77 (Mar 24) to 4.48, marking a decrease of 0.29.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.14. This value is below the healthy minimum of 0.2. It has decreased from 0.21 (Mar 24) to 0.14, marking a decrease of 0.07.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.30. This value is within the healthy range. It has decreased from 0.47 (Mar 24) to 0.30, marking a decrease of 0.17.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 1.23. It has increased from 1.17 (Mar 24) to 1.23, marking an increase of 0.06.
• For Current Ratio (X), as of Mar 25, the value is 1.89. This value is within the healthy range. It has increased from 1.37 (Mar 24) to 1.89, marking an increase of 0.52.
• For Quick Ratio (X), as of Mar 25, the value is 1.19. This value is within the healthy range. It has increased from 0.77 (Mar 24) to 1.19, marking an increase of 0.42.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 6.01. This value is within the healthy range. It has increased from 2.77 (Mar 24) to 6.01, marking an increase of 3.24.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 4.63 (Mar 24) to 0.00, marking a decrease of 4.63.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 2.76 (Mar 24) to 0.00, marking a decrease of 2.76.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 95.37 (Mar 24) to 0.00, marking a decrease of 95.37.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 97.24 (Mar 24) to 0.00, marking a decrease of 97.24.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 5.47. This value is within the healthy range. It has decreased from 7.82 (Mar 24) to 5.47, marking a decrease of 2.35.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 3.05. This value is within the healthy range. It has decreased from 4.60 (Mar 24) to 3.05, marking a decrease of 1.55.
• For Enterprise Value (Cr.), as of Mar 25, the value is 6,230.59. It has increased from 4,979.10 (Mar 24) to 6,230.59, marking an increase of 1,251.49.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.61. This value is within the healthy range. It has decreased from 2.09 (Mar 24) to 1.61, marking a decrease of 0.48.
• For EV / EBITDA (X), as of Mar 25, the value is 14.70. This value is within the healthy range. It has decreased from 17.53 (Mar 24) to 14.70, marking a decrease of 2.83.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.49. This value is within the healthy range. It has decreased from 1.89 (Mar 24) to 1.49, marking a decrease of 0.40.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 95.36 (Mar 24) to 0.00, marking a decrease of 95.36.
• For Price / BV (X), as of Mar 25, the value is 2.77. This value is within the healthy range. It has decreased from 3.47 (Mar 24) to 2.77, marking a decrease of 0.70.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.49. This value is within the healthy range. It has decreased from 1.89 (Mar 24) to 1.49, marking a decrease of 0.40.
• For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.02.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness